T he bone-added osteotome sinus floor elevation (BAOSFE) technique 1 and its reported modifications [2] [3] [4] [5] represent substantially less invasive and less costly alternatives for predictable implant installation in the moderately deficient posterior maxilla. Introduced by Summers 1 in 1994, the BAOSFE procedure uses tapered concave-tipped osteotomes and graft materials to facilitate sinus floor elevation (SFE) with concurrent implant placement. Osteotomes are used to apically displace the graft materials, fracturing the sinus floor and elevating the schneiderian membrane. After this "bone-cushioned" SFE and addition of more of the graft mixture, an implant, referred to as "the final osteotome," is inserted resulting in a tented grafting area with elevation of the sinus floor for several millimeters. 1 Many reports have applied modifications to Summers' original BAOSFE protocol to expedite the procedure, minimize malleting force, and simplify sinus floor infracture. [2] [3] [4] Other authors have suggested modifications to the BAOSFE procedure in terms of instrumentation, 6 -10 grafting materials, [11] [12] [13] [14] and implant surface and design. 4, 15, 16 Clinical studies on osteotomemediated SFE (OMSFE) with simultaneous implant placement show a success rate between 88.6% and 100%. [1] [2] [3] 12, [15] [16] [17] [18] [19] [20] [21] [22] [23] The primary determinant in implant survival with OMSFE procedures is the residual subantral bone height (RSBH).
3, 20 Summers 1 claimed that a preoperative RSBH of at least 5 to 6 mm was needed for predictable implant success with the BAOSFE procedure, and this has been confirmed by other reports. 2, 3, 7, 12, 20 A review of the literature indicates that the implant type, the choice of graft material, the absence of graft material, and the method of sinus floor infracture (direct or bone cushioned) exerted minimal influence on survival outcome; however, factors such as edentulism, osteoporosis, and an overdenture prosthesis have been shown to influence postloading survival of implants placed in areas of limited RSBH. 3 Grafting material is traditionally used in combination with OMSFE to create more bone volume to aid in support of the implant. However, there is no conclusive data in the literature reporting on the possible advantage and maturation of a bone graft at the apical portion of the implant. 24, 25 In fact, recent reports have demonstrated similar degrees of localized SFE or endo/sinus bone gain (3-4.5 mm) and equivalent implant survival rates (94%-100%), using no grafting materials, 12,13,23,26 -28 suggesting that the mere tenting of the schneiderian membrane by the implant apex could initiate subantral bone formation.
The authors' currently preferred OMSFE technique uses platelet-rich fibrin (PRF) as the grafting material to accelerate wound healing 14, 29, 30 and to provide membrane protection during elevation and implant insertion. PRF is a second generation platelet concentrate 31,32 prepared from centrifuged blood. Simple centrifugation of whole blood with no additives produces an autologous fibrin matrix rich in platelet and leukocyte growth factors. It is hypothesized that these soluble molecules are trapped in the fibrin meshes of PRF and can be slowly released producing a relatively long-term effect for Ͼ7 to 14 days. 31 PRF is also an inexpensive and easily handled material with healing properties on the sinus membrane 14 and bone. 29, 30, 33, 34 It provides protection for the sinus membrane during the use of the osteotome, and in case of perforation, the fibrin matrix could help the wound closure. 14, 35 Diss et al 14 documented radiographic changes in the apical bone levels on 20 patients with 35 microthreaded implants placed using OMSFE with PRF. Measurements of the changes in the endo/sinus bone level were attained radiographically and showed a mean gain of 3.2 mm with the procedure. Despite a limited RSBH (4.5-8 mm), a healing period of 2 to 3 months was found to be sufficient to resist a torque of 25 Ncm applied during abutment tightening. One implant failed during the initial healing, but at 1 year, all implants were clinically stable, and the definitive prostheses were in function, resulting in a survival rate of 97.1%.
The predictability of OMSFE with or without graft materials has been clearly confirmed in previous articles. [2] [3] [4] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [25] [26] [27] [28] This article demonstrates similar early success and presents a rationale for incorporating concentrated autologous growth factors (PRF) into the procedure.
MATERIALS AND METHODS
Between November 2008 and January 2010, in 110 patients, 138 sites were treated; of these, 70 (92 sites) were women and 40 (46 sites) were men. Patient age ranged from 34 to 90 years (mean age, 58.4 years). Both partially and completely edentulous (3) patients were included. The estimated RSBH, as measured on a preoperative digital radiograph, was 4 to 8 mm. Intraoperative radiographic measurements were performed during surgery to more accurately assess the RSBH, so that the depth of sinus penetration could be estimated after implant placement. All implants penetrated at least 2 mm beyond the original level of the sinus floor.
PRF Preparation
During surgery, 18 to 54 mL (2-6 tubes) of whole blood was drawn into 9-mL glass-coated plastic tubes without anticoagulant and immediately centrifuged (PRF Process, Nice, France) at 2700 rpm for 12 minutes. Within a few minutes, the absence of anticoagulant induced the activation of platelets contained in the sample, thus triggering a coagulation cascade. The result was a fibrin clot located in the middle of a mass of acellular plasma, with a maximum number of platelets and more than half of the leukocytes caught in the mesh of fibrin. The clot was removed from the tube with a forceps (Fig. 1) , and the attached red blood cells were shaved off and discarded. The clots were then placed on a grid in the PRF box (PRF Process) and compressed by a cover (masher) to create a fibrin membrane (Fig. 2) . Alternatively, the clots were also placed in cylinders contained in the box and compressed by pistons to create a fibrin plug (Fig. 3) . PRF plugs are preferred over the membranes because they are simpler to insert, compress, and apically displace in the prepared osteotomy.
Implant Selection
The distribution of the 138 screwtype implants was as follows:
• sixty-four Neoss ProActive implants, 3 
OMSFE/PRF Surgical Technique
All patients were premedicated with 2.0 g of amoxicillin or 500 mg of azithromycin 1 hour before surgery. Just before anesthesia, the patient rinsed with 0.12% chlorhexidine gluconate for 1 minute, and the surgical site was cleaned thoroughly with the same solution or Betadine on a cotton swab.
Full-thickness flaps were elevated after a midcrestal incision. Flap reflection was usually minimized but had to provide for adequate access and visualization to the entire ridge crest.
The authors used personally designed rapid-expansion-limited-bone (RELB) osteotomes (H&H Co., Ontario, CA) for localized SFE and simultaneous implant placement in areas of limited bone height (4.0 -8.0 mm). The RELB osteotomes are marked at 4, 5, 6, 8, and 10 mm, are 2.0 to 5.5 mm in diameter, and have either a 0.5-mm tapered tip or are parallel-sided (Fig. 4) . The osteotomes of choice must be available in straight or offset design because access to first and second molar sites is very often limited with straight osteotomes and can result in less than ideal axial inclination of the implant and trauma to the lower lip. Osteotomes with a 30-degree offset are preferred as they provide adequate access without sacrificing tactile sensitivity or instrument stability. A surgical mallet (H&H Co.) was used to advance the osteotomes.
The osteotome technique favored by the authors most closely resembles a modification of Summers' BAOSFE technique, 1 termed localized sinus lift, first reported by Cavicchia et al 2 and further refined by Toffler.
3 The technique was performed in 4 steps: (1) crestal bone site preparation with calibrated drills, (2) direct sinus floor fracture with an osteotome, (3) sinus membrane elevation with PRF as the grafting material, and (4) implant placement.
By using a surgical template to aid in implant positioning, an osteotomy was initiated at the future implant site with a 2.0-mm round bur. A 2.0-mm twist drill was then advanced to a depth that was 0.5 to 1 mm from the sinus floor (working depth) as measured from the preoperative radiograph. A 2.0-to 2.2-mm wide calibrated guide pin was then inserted into the osteotomy, and this ideal subsinus position was confirmed radiographically before proceeding (Fig. 5) . Another measurement of the RSBH was then taken by measuring the distance from the guide pin apex to the sinus floor and adding it to the known depth of the inserted pin. This measurement was recorded for each patient as the RSBH before OMSFE. If a perforation was created and detected ( Fig. 6 ) during initial drilling (3 patients), a calibrated probe was inserted to get an accurate reading of the RSBH. Once the working depth had been established, the site was then completely prepared with the conventional sequence of drills needed for the placement of an implant of the selected diameter. As the diameter of the osteotomy was widened, the surgeon ascertained the residual bone quality. This determined the degree to which the osteotomy was to be underprepared relative to the final implant diameter (range, 0.5-1.2 mm) to improve primary implant stability. In the interest of patient comfort, the authors widened the osteotomy using drills only, remaining 0.5 to 1 mm below the floor of the sinus. The final diameter of the osteotomy was 0.5 to 1.2 mm smaller than the implant diameter. Consistently maintaining the working depth and drilling to within Յ1 mm of the sinus floor minimizes the malleting force required to displace residual bone beneath the sinus floor, thereby reducing the possibility of membrane perforation because of uncontrolled apical penetration of the osteotome. The patient's head was stabilized while malleting the osteotomes by placing firm pressure on the forehead. A calibrated straight or offset RELB osteotome consistent with the apical diameter of the last drill used for implant site preparation was used to achieve the initial sinus floor infracture. If the osteotome was not easily advanced, a slightly narrower (Ϫ1.0 mm) osteotome was used or additional apical preparation with drills was performed to pierce a dense spot in the bone. The moment of induced greenstick fracture of the sinus floor was easily recognized as the layer of cortical bone forming the floor was displaced apically carrying the membrane up with it (Fig. 7) . Immediately after infracture, the implant site was tested for perforation of the sinus membrane by direct inspection and the Valsalva maneuver, which was performed by asking the patient to blow through the nose (after pinching the nostrils), while holding a mirror directly underneath the osteotomy site. Two perforations were detected after infracture using the maneuver. Once membrane integrity had been verified, 2 to 4 membranes or plugs made of PRF were added to the osteotomy (Fig. 8 ) and compressed apically (Fig. 9) into the developing subantral space by inserting the osteotome to a depth equal to the measured RSBH. The PRF acts as a "membrane insurance" to possibly seal any undetected perforation and provides tenting of the antral membrane in advance of implant placement. Sites where a perforation was detected (5 sites), PRF was inserted in the osteotomy, and an implant was placed no Ͼ2.0 to 3.0 mm into the Fig. 5 . Periapical radiograph of a 2.2-mm Neoss depth gauge confirms the ideal "working depth" of 7.0 mm before the drilled expansion of the osteotomy. Fig. 6 . Small 2-mm perforation detected on the mesial aspect of the osteotomy as site 14. After insertion of 2 PRF plugs, a 9-mm implant will be safely placed, measuring 2 to 3 mm longer than the RSBH. sinus cavity. If the RSBH was Յ5 mm or the patient was using a removable prosthesis to replace the missing teeth, the implants were submerged to prevent inadvertent early loading. An immediate postoperative periapical radiograph was taken to confirm sinus floor intrusion and ideal implant positioning (Fig. 10) . The extent of SFE was determined by subtracting the intraoperatively measured RSBH from the implant length.
After surgery, all patients received (1) oral antibiotics for an additional 3 to 6 days, (2) nonsteroidal analgesics for 3 to 5 days, (3) detailed instructions about oral hygiene (mouth rinses with 0.12% chlorhexidine for 2 weeks), and (4) sinus-specific instructions for the next 7 days including (a) no smoking or sipping through a straw, (b) sneezing with an open mouth, (c) no blowing of the nose, and (d) use of intranasal antihistamine medication for 72 hours. Fixed prostheses were immediately replaced and relieved in the pontic area to avoid traumatizing the surgical site. Removable prostheses were relined and replaced 2 to 3 weeks postoperatively. Sutures were removed 8 to 15 days after surgery. Implants were allowed to heal for a minimum of 3 months before second-stage surgery if required. Implant stability was tested with an Osstell (Osstell AB, Gothenberg, SW) device, and a new periapical radiograph was taken to evaluate the new position of the sinus floor relative to the implant apex (Fig. 11) . Healing abutments were placed if second-stage surgery was required, and the implants were restored 2 to 3 weeks later. Implant survival criteria were as follows: (1) absence of clinically detectable implant mobility; (2) absence of pain or any subjective sensation; (3) absence of recurrent periimplant infection; and (4) absence of continuous radiolucency around the implant.
RESULTS
Between November 2008 and January 2010, 138 OMSFE/PRF procedures were performed in 110 patients. These procedures were accomplished at 8 second molar sites, 62 first molar sites, 54 second bicuspid sites, and 14 first bicuspid sites. The mean RSBH of the alveolar crest was 6.6 mm (range, 4 -8 mm). The mean increase in the height of implant sites by OMSFE was 3.4 mm (range, 2.5-5 mm). A variety of implant lengths were used, including 8.0 to 8.5 mm (n ϭ 7), 9 mm (n ϭ 22), 10 mm (n ϭ 59), and 11.0 to 11.5 mm (n ϭ 48). At the time of statistical analysis, of the 138 implants that had been placed, 97 had been restored and in function for an average loading time of 5.2 months (range, 1-11 months). The mean healing time for the loaded implants was 4 months until abutment insertion (range, 3-5 months). Five sinus membrane perforations were detected for a detectable perforation rate of 3.6%. Three occurred during the initial drilling and measured 2 mm in diameter, and two were discovered immediately after sinus floor infracture. Three implants were lost, all before loading. Two implants failed 4 weeks postoperatively because of infection. One of the implants was placed at the time of extraction, and the other was placed 8 weeks after extraction. At both sites, 3 to 4 mm of localized SFE and crestal bone augmentation were performed. At the immediate site, a perforation was detected at the time of sinus floor infracture. At the delayed site, the RSBH measured 4 mm. Both implants were replaced 4 months later without complication using OMSFE and PRF. The third implant failure occurred in a totally edentulous maxilla at uncovering because of rotational instability. This implant was placed in 4 mm of RSBH, and the patient wore her maxillary full denture throughout the healing process of 5 months. It seems that the presence of minimal RSBH, uncontrolled denture related forces, and sinus perforation increased the risk for failure because of reduced primary stability, occlusal trauma, and localized inflammatory or an altered healing response at a perforated sites. After surgery, 3 patients experienced nasal congestion and headache that abated within a few days with the use of nasal decongestants and prolonged antibiotics. One of these patients did experience a perforation during the procedure. At up to 11 months of loading, all restored implants were clinically stable. When the restored and unrestored implants are combined, the early survival rate is 97.8%.
DISCUSSION
A variety of SFE procedures have been proven to be successful in augmenting the subantral bone volume in the atrophic posterior maxilla. 36 -45 However, many of these techniques are costly and invasive and require extensive treatment time. This was the rationale for Summers' development of OMSFE procedures. 1, 46, 47 Early reports on OMSFE incorporated particulate graft materials to aid in sinus floor infracture and tenting of the sinus membrane around the implant apex. 1, 4 When using osteotomes to apically displace these potentially sharpedged graft materials and bone chips, perforation of the sinus membrane may occur, but the real disadvantage is that if the internal SFE is performed this way, there is no opportunity to detect perforations unless they are very large. 22 Displacement of graft material through the sinus membrane is a great concern, as it can lead to transient or chronic sinusitis in 10% to 20% of sinus elevation cases, prompting the need for additional treatment.
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Postoperative sinus infection, even if treated early with antibiotics and saline rinsing, can potentially destroy the graft material and jeopardize implant success. In addition, if repeated hard malleting of a column of graft material does not result in sinus infracture, the graft plug must be removed, additional apical preparation performed, and the grafting procedure repeated. Cavicchia et al. 2 and Toffler 3, 45 found that the bone-cushioned approach was impractical unless the subantral bone was extremely soft and a definite sinus floor was not present, a feature that, in their experience, was not frequently found. These clinical concerns and the reported success of OMSFE without particulate grafts 12-14,23,26 -28 have prompted many clinicians to exclude graft materials when performing OMSFE. For the less-experienced clinician, direct infracture without bone cushioning may increase the risk of membrane perforation, but as one becomes more familiar with the tactile and auditory changes associated with sinus floor encroachment, modification of the applied malleting force results in a more controlled, less traumatic infracture. 3 Most authors report an average bone height gain of 3 to 4 mm using traditional osteotome procedures, 3, 15, 19, 22 and this report confirms their findings (Figs. 12 and 13 ). Greater degrees of elevation are attainable, but it will certainly increase the incidence and size of membrane perforation. 10, 24 Fortunately, membrane perforations seem to have no longterm effect on implant survival, but it is more likely that a patient would experience postoperative complications at perforated sites. It is the authors' opinion and standard operating protocol that at perforated sites, no particulate materials should ever be placed, solely 2 plugs of PRF, which are inserted and apically displaced to the working depth. The selected implant length should not be Ͼ2 to 3 mm than that of the original RSBH. If this does not allow for the placement of an implant at least 8 to 9 mm in length, the site is abandoned, and implant placement is delayed for 3 months. This perforation protocol would seem justified in light of the fact that in the majority of cases, small rifts of the schneiderian membrane will not disturb the healing process, 12 and protrusion of an implant 2 to 3 mm into the sinus without grafting material does not adversely affect apical bone formation or implant success. 13, [52] [53] [54] A previous report has noted a decreased survival rate (23%) on implants placed in Ͻ5 mm of RSBH. 3 In this study, 2 of 6 sites that had 4 mm of RSBH failed; 1 at 4 weeks and the other at uncovering because of rotational instability. On the basis of more recent clinical experience, the authors will place and submerge implants at sites with 4 mm of RSBH using OMSFE/PRF only if they achieve excellent primary stability with an implant stability quotient of 65 or more and they are to be part of a multiple implant-splinted restoration. 55 It is felt that these surgical and restorative restrictions and the incorporation of PRF and its slow release of growth factors would provide equivocal success to those sites with Ն5-mm RSBH. The early results of this study are in accordance with many published reports documenting both the predictability and the reliability of OMSFE procedures. [12] [13] [14] 22, 23 CONCLUSIONS PRF may be used in lieu of particulate grafting to predictably elevate the sinus floor using a crestal approach. The authors use PRF whenever possible in OMSFE procedures based on its reported efficacy in membrane repair 14, 35 and its ability to reduce sinus graft healing time. 29 The PRF membrane, or plug, also provides protection for the sinus membrane during the use of an osteotome, and in case of perforation, the fibrin matrix can aid in wound closure.
14 OMSFE procedures will continue to gain popularity in an economic environment that favors less-invasive and more affordable implantsupported rehabilitation of the posterior maxilla. The incorporation of shorter implants, 56, 57 as well as easily obtained and inexpensive patientderived growth factors such as PRF, 58 can readily compliment OMSFE so as to shorten treatment time, expand the indications, and broaden the appeal of a minimally invasive approach to treating the moderately atrophic posterior maxilla.
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The authors thank surgical assistants Tracey Lindsay, Gricel Crespo, Fig. 11 . After 4 months of healing, the new apical position of the sinus floor is evident. Fig. 12 . Keystone XP-1 4.8 ϫ 10-mm implant placed at site 14 with 4 mm of localized SFE. Note: localized inflammatory response in membrane to elevation with PRF. Fig. 13 . After 3.5 months, the sinus floor is now located at the implant apex. Resultados: El altura media residual del hueso subantral (RSBH) de la cresta alveolar fue 6.6 mm (variación de 4 a 8 mm). El aumento medio de la altura en los lugares de los implantes con OMSFE/PRF fue 3.4 mm (variación de 2.5 a 5 mm). Se usaron una variedad de implantes tipo tornillo de 8 a 11.5 mm de largo (longitud media de 10.1 mm) y de 3.5 a 6 mm de ancho (ancho medio de 4.4 mm). De los 138 implantes que se habían colocado, 97 fueron restaurados y en función durante un período de carga promedio de 5.2 meses (variación de 1 a 11 meses). El período medio de curación para los implantes cargados fue de 4 meses hasta la colocación del pilar (variación de 3 a 5 meses). Tres implantes fallaron antes de la carga para lograr una tasa de supervivencia inicial de los implantes cargados y sin cargar del 97.8%. Conclusión: Una evaluación inicial de la técnica OMSFE/PRF presentada para la elevación localizada del piso del seno y colocación del implante demuestra un alto grado de seguridad y éxito en lugares con RSBH de 5 a 8 mm. 4 a 8 mm) . O aumento médio na altura dos locais de implante por OMSFE/PRF era 3.4 mm (variação 2.5 a 5 mm). Uma variedade de implantes tipo parafuso de 8 a 11.5 mm de comprimento (extensão média 10.1 mm) e 3.5 a 6 mm de largura (largura média 4.4 mm) foi usada. Dos 138 implantes que haviam sido colocados, 97 foram restaurados e estiveram em funcionamento por um tempo de carregamento médio de 5.2 meses (variação 1 a 11 meses). O tempo de cura médio para os implantes carregados foi 4 meses até a inserção do suporte (variação 3 a 5 meses). Três implantes falharam antes do carregamento para uma taxa de sobrevivência precoce tanto dos implantes carregados quanto dos descarregados de 97.8%. Conclusão: A revisão precoce da técnica OMSFE/PRF apresentada para elevação localizada da superfície da cavidade e colocação de implante demonstra um alto grau de segurança e sucesso em locais com RSBH de 5 a 8 mm. 
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